Advertisement
Screener

Pacific Biosciences of California, Inc. (PACB) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

Pacific Biosciences of California, Inc. Cash Flow Breakdown

Cash flow breakdown shows where Pacific Biosciences of California, Inc.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $111.21M went out.
  • Fiscal year ended 2025-12-31: from investing, $115.45M came in.
  • Fiscal year ended 2025-12-31: from financing, $3.43M came in.
  • Fiscal year ended 2025-12-31: change in cash, $7.67M came in.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingBuybacksNew shares soldOtherNot split outChange in cash
2025-12-31-$111.21M$115.45M$0.00$3.43M*$7.67M
2024-12-31-$206.06M$124.00M$0.00-$42.99M*-$125.04M
2023-12-31-$259.17M$4.60M$189.20M$0.00-$80.31M*-$145.68M
2022-12-31-$263.21M$116.08M$0.00$0.00$9.62M*-$137.51M
2021-12-31-$111.18M-$678.53M$31.81M-$245.00K$1.14B*$379.87M
2020-12-31$19.50M-$219.32M$46.36M$205.48M*$52.02M
2019-12-31-$78.31M$62.05M$8.55M$18.00M*$10.28M
2018-12-31-$66.43M-$38.41M$9.65M$97.53M*$2.34M
2017-12-31-$67.52M-$1.55M$8.91M$59.90M*-$258.00K
2016-12-31-$67.93M-$14.86M$7.73M$58.20M*-$16.86M
2015-12-31-$47.89M$8.61M$7.36M$29.10M*-$2.82M
2014-12-31-$51.47M$19.56M$3.97M$38.02M*$10.09M
2013-12-31-$29.83M-$33.12M$3.08M$39.69M*-$20.18M
2012-12-31-$76.82M$61.79M$2.71M-$12.32M
2011-12-31-$102.97M$6.45M$7.74M-$88.78M
2010-12-31-$122.00M-$138.25M$212.52M$106.14M*$58.42M
2009-12-31-$74.84M$18.59M-$8.00K$311.00K$66.71M*$10.77M

Each quarter (3 month)

Quarter endRunning the businessFrom investingNew debtNew shares soldOtherNot split outChange in cash
2026-06-30-$35.58M*$40.07M*
2026-03-31-$44.69M$35.86M$1.44M*-$7.39M
2025-12-31-$19.07M*$26.03M*
2025-09-30-$18.71M*$18.90M*$1.47M*
2025-06-30-$29.38M*$25.28M*
2025-03-31-$44.06M$45.23M$1.96M*$3.14M
2024-12-31-$30.65M*$58.24M*$0.00*-$50.20M*
2024-09-30-$45.46M*$23.07M*$0.00*$812.00K*
2024-06-30-$54.26M*$76.84M*$0.00*
2024-03-31-$75.68M-$34.14M$0.00$6.55M*-$103.27M
2023-12-31-$57.56M*-$66.58M*$0.00*-$81.60M*
2023-09-30-$65.18M*$242.32M*$0.00*-$781.00K*
2023-06-30-$41.74M*-$98.59M*$0.00*-$4.71M*
2023-03-31-$94.69M-$72.55M$189.20M$6.79M*$28.75M
2022-12-31-$60.57M*$80.40M*$0.00*$819.00K*
2022-09-30-$63.05M*$53.91M*$0.00*$3.13M*
2022-06-30-$60.56M*-$60.28M*$0.00*
2022-03-31-$79.03M$42.05M$0.00$5.21M*-$31.76M
2021-12-31-$31.71M*$65.75M*$1.69M*$1.00K*
2021-09-30-$40.66M*-$291.65M*$4.81M*$0.00*$294.85M*
2021-06-30-$15.71M*-$460.81M*$2.97M*$0.00*
2021-03-31-$23.10M$8.17M$22.34M-$246.00K$843.62M*$850.79M
2020-12-31-$14.26M*-$98.50M*$32.19M*$93.69M*
2020-09-30-$17.81M*-$63.64M*$13.35M*$93.79M*
2020-06-30-$23.79M*-$2.86M*$628.00K*
2020-03-31$75.36M-$54.33M$199.00K$18.00M*$39.23M
2019-12-31-$18.18M*-$3.41M*$131.00K*$18.00M*
2019-09-30-$17.26M*$19.66M*$327.00K*
2019-06-30-$17.56M*$7.81M*$1.40M*
2019-03-31-$25.31M$37.98M$6.69M$19.36M
2018-12-31-$18.98M*-$5.51M*$5.47M*
2018-09-30-$14.18M*-$37.34M*$1.66M*$64.86M*
2018-06-30-$14.50M*$12.19M*$30.00K*
2018-03-31-$18.77M-$7.75M$2.49M$32.99M*$8.95M
2017-12-31-$20.20M*$10.68M*$96.00K*-$9.42M*
2017-09-30-$17.84M*$4.88M*$2.59M*-$10.55M*
2017-06-30-$12.81M*-$42.59M*$2.82M*$60.07M*$7.50M*
2017-03-31-$16.67M$25.48M$3.41M$12.22M
2016-12-31-$12.90M*$6.67M*$200.00K*-$6.03M*
2016-09-30-$15.88M*$10.87M*$3.03M*-$1.98M*
2016-06-30-$18.89M*-$9.16M*$1.08M*$31.66M*$4.70M*
2016-03-31-$20.27M-$23.24M$3.42M$26.54M*-$13.55M
2015-12-31-$714.00K*-$22.43M*$1.90M*$27.67M*$6.42M*
2015-09-30-$15.77M*$14.57M*$2.48M*$1.28M*
2015-06-30-$7.49M*$1.17M*$550.00K*$1.43M*-$4.34M*
2015-03-31-$23.91M$15.30M$2.43M-$6.18M
2014-12-31-$15.36M*-$1.51M*$649.00K*$17.25M*$1.04M*
2014-09-30-$6.24M*$12.70M*$628.00K*$7.21M*
2014-06-30-$13.62M*$179.00K*$380.00K*-$13.06M*
2014-03-31-$16.26M$8.20M$2.31M$20.65M*$14.90M
2013-12-31-$14.57M*-$24.15M*$348.00K*-$38.41M*
2013-09-30$18.72M*$3.76M*$1.45M*$23.93M*
2013-06-30-$16.41M*-$7.14M*$0.00*$48.00K*$11.30M*-$12.21M*
2013-03-31-$17.57M-$5.58M$20.50M$1.24M$7.92M*$6.50M
2012-12-31-$18.22M*$32.20M*$2.00K*$13.98M*
2012-09-30-$17.65M*$15.90M*$683.00K*-$1.06M*
2012-06-30-$23.61M*$710.00K*$265.00K*-$22.64M*
2012-03-31-$17.34M$12.98M$1.75M-$2.60M
2011-12-31-$14.77M*$15.80M*$257.00K*$1.28M*
2011-09-30-$23.85M*$23.08M*$3.83M*$3.07M*
2011-06-30-$30.89M*-$2.53M*$3.32M*-$30.10M*
2011-03-31-$33.46M-$29.91M$333.00K-$63.03M
2010-12-31-$39.05M*-$87.51M*$211.22M*$84.93M*
2010-09-30-$33.35M*-$2.51M*$8.44M*-$27.43M*

Similar stocks

Stock NameCountryMarket CapPE Ratio
908 Devices Inc. (MASS)United States$0.476B-9.53
EyePoint, Inc. (EYPT)United States$0.314B-3.96
Cytek Biosciences, Inc. (CTKB)United States$0.744B-7.15
Quanterix Corp (QTRX)United States$0.150B-1.65
Nautilus Biotechnology, Inc. (NAUT)United States$0.129B-4.16
Seer, Inc. (SEER)United States$0.104B-1.34
Precipio, Inc. (PRPO)United States$0.043B-36.70
HARVARD BIOSCIENCE INC (HBIO)United States$0.037B-2.70
Bionano Genomics, Inc. (BNGO)United States$0.020B-0.42
ASTROTECH Corp (ASTC)United States$0.013B